Novartis teams test combinations of targeted therapeutic agents to combat drug resistance in tumors.

Novartis collaborates with Homology Medicines to adapt and refine genome editing technology.

Novartis collaborates with the Banner Alzheimer’s Institute to test treatments for preventing Alzheimer’s disease.

Novartis is developing an experimental drug for weight loss.

Learn how Novartis researchers are working to outsmart tumors.

Learn about the career of our Global Medical Affairs Head for Solid Tumors and Rare Diseases.

Experimental treatments for Alzheimer’s disease put the amyloid cascade hypothesis to the test.

Yan Zhao talks about how her team in China responded to an emerging public health crisis.

A new compound aims to attack dangerous antibiotic-resistant bacteria.